New patent expiration for Purdue Pharma drug RYZOLT
Annual Drug Patent Expirations for RYZOLT Ryzolt is a drug marketed by Purdue Pharma and is included in one NDA. […]
New patent expiration for Purdue Pharma drug RYZOLT Read Post »
Patent Expiration
New patent expiration for Sandoz drug RECLAST
Annual Drug Patent Expirations for RECLAST Reclast is a drug marketed by Sandoz and is included in one NDA. It
Drug Patent Expirations for the Week of October 22, 2023
FINACEA (azelaic acid) Leo pharma as Patent: 8,900,554 Expiration: Oct 24, 2023 See More … For more information on how
Drug Patent Expirations for the Week of October 22, 2023 Read Post »
New patent expiration for Optinose Us drug XHANCE
Annual Drug Patent Expirations for XHANCE Xhance is a drug marketed by Optinose Us Inc and is included in one
New patent expiration for Optinose Us drug XHANCE Read Post »
New patent expiration for Leo Pharma drug FINACEA
Annual Drug Patent Expirations for FINACEA Finacea is a drug marketed by Leo Pharma As and is included in two
New patent expiration for Leo Pharma drug FINACEA Read Post »
New patent expiration for Am Regent drug INJECTAFER
Annual Drug Patent Expirations for INJECTAFER Injectafer is a drug marketed by Am Regent and is included in one NDA.
New patent expiration for Am Regent drug INJECTAFER Read Post »
New patent expiration for Novartis drug VOTRIENT
Annual Drug Patent Expirations for VOTRIENT Votrient is a drug marketed by Novartis and is included in one NDA. It
New patent expiration for Novartis drug VOTRIENT Read Post »
Drug Patent Expirations for the Week of October 15, 2023
LUPKYNIS (voclosporin) Aurinia Patent: 7,332,472 Expiration: Oct 17, 2023 See More … For more information on how DrugPatentWatch can help
Drug Patent Expirations for the Week of October 15, 2023 Read Post »
New patent expiration for Aurinia drug LUPKYNIS
Annual Drug Patent Expirations for LUPKYNIS Lupkynis is a drug marketed by Aurinia and is included in one NDA. It
